CLINICAL_TRIALS
trial_result
· 2024-07-09
Clinical Trial Update: A Study of Maribavir in Japanese People With Cytomegalovirus (CMV) Infection [Phase 3]
Summary
Phase 3 trial in Japanese patients with cytomegalovirus infection has completed and posted results for maribavir.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Cytomegalovirus (CMV) | Phase 3 | Status: COMPLETED | Results posted: 2024-07-09